Swedish private equity firm EQT Partners is poised to sign on the dotted line to acquire one of Australia’s largest veterinary chains, VetPartners.
Street Talk can reveal EQT dealmakers, Frank Heckes and David Forde, have agreed terms with sell-side adviser Jefferies and the buyout firm has been anointed preferred bidder.
EQT, who you can meet at the Benelux Private Equity Conference, was understood to have bid upwards of $1.4bn in the first round – giving VetPartners the same multiple implied by TPG Capital’s sale of a 45 per cent stake in GreenCross last year. However, limited partner sources suggested the final agreed price was slightly lower following a period of more in-depth due diligence.
As this column reported last week, binding offers for the up-for-grabs veterinary chain, which makes about $131m a year, were received from EQT and rival private equity firm Affinity Equity Partners.
The fast-tracked auction was being run by Jefferies with expectations of a circa $1.4bn sale. Affinity Equity Partners had Macquarie Capital’s bankers while EQT was being advised by Morgan Stanley.
VetPartners has 267 clinics in Australia, New Zealand and Singapore, which helped it make $661m revenue and $131m EBITDA for the 2023 financial year. The business, whose global parent is National Veterinary Associates, first caught EQT’s attention in August.
The buyout giant has chased furry deals aggressively over the past decade. It has owned European and North American vet roll-up IVC Evidensia and its 2500 clinics since 2014. It also invested in British insurer ManyPets, and tag-teamed with the Abu Dhabi Investment Authority to take London-listed veterinary drugmaker Dechra private for £4.46bn ($8.9 bn).
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
EQT opened shop in Australia in February 2020 with just three people. It’s since grown to over 50, deployed $8bn on deals in the country and is among the firms that considered a run at ASX-listed Healius, the healthcare services provider subject to a potential takeover by Australian Clinical Labs. EQT also teamed up with Regal Partners last November to try to acquire Perpetual.
Jefferies has been shepherding suitors through a tight timetable, thanks to NVA’s plan to float the leftover business. Interested parties, which were understood to include Affinity, Goldman Sachs’ private equity division and Permira Private Equity, were given only a few weeks to make up their minds about VetPartners and asked to lob non-binding indicative bids by end of August.
With the sale nearing completion, California headquartered NVA plans to split the $6bn-a-year ($9bn) global business into two separate units: Ethos Veterinary Health would have 145 animal hospitals and $2bn annual revenue; and NVA would have 1400 locations including animal general practices, equine hospitals and pet resorts.
Source: AFR
Can’t stop reading? Read more
Madrid’s Swiftair lands Antin as new majority backer to expand European routes
Madrid’s Swiftair lands Antin as new majority backer to expand European routes Antin...
Thoma Bravo backs SDC Capital with minority stake to accelerate data centre push
Thoma Bravo backs SDC Capital with minority stake to accelerate data centre push Thoma Bravo has...
Alantra, Generali, PAI Partners, and Draycott map out Iberia’s next phase of private equity
Alantra, Generali, PAI Partners, and Draycott map out Iberia’s next phase of private equity...